Skip to main content
Smart Investors Daily
PR

NASDAQ · PRN

Invesco Dorsey Wright Industrials Momentum ETF

Financial Services · Asset Management

$192.35

Up+$1.89 (+0.99%)

Updated Nov 11, 2026, 11:42 AM

SID Score

3.6/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
345.53M
P/E ratio
—
Dividend yield
0.28%
52-week range
$182.75 – $262.73
Volume
20.44K
Avg. volume
15.93K

Price performance · PRN

PRN price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Nov 10, 2026

PRN closed at $192.35 after 21 trading sessions, down 3.15% for the selected period.

Last close
$192.35
Period change
-3.15%
Period low
$183.59
Period high
$198.61
Daily close
View OHLC price history
PRN OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 10, 2026$190.41$192.45$190.0675$192.3520.44K
Nov 9, 2026$186.58$191.27$186.58$190.456822.77K
Nov 6, 2026$184.41$185.06$182.75$184.5419.4K
Nov 5, 2026$192.29$192.40$183.53$183.58537.56K
Nov 4, 2026$196.70$196.70$191.71$192.805425.34K
Nov 3, 2026$194.92$197.205$194.92$195.652613.83K
Nov 2, 2026$194.53$196.895$194.5157$194.515713.05K
Oct 30, 2026$196.21$196.21$192.6601$193.48766.76K
Oct 29, 2026$195.96$197.1249$195.9401$196.76083.26K
Oct 28, 2026$195.88$196.785$195.065$195.768.95K
Oct 27, 2026$196.87$196.87$195.23$195.53996.37K
Oct 26, 2026$194.31$196.525$194.31$196.18314.72K
Oct 23, 2026$191.93$193.87$191.78$193.405680.22K
Oct 22, 2026$193.225$193.225$190.31$192.115323.28K
Oct 21, 2026$193.97$194.99$193.82$194.907319.33K
Oct 20, 2026$192.06$193.28$191.38$192.481914.46K
Oct 19, 2026$193.25$194.0828$192.19$192.32188.3K
Oct 16, 2026$195.66$196.63$192.4901$193.126.35K
Oct 15, 2026$194.40$195.34$192.58$195.175319.17K
Oct 14, 2026$197.155$197.25$194.89$195.64916.86K
Oct 13, 2026$197.79$198.69$196.25$198.608513.7K

Latest PRN news

The latest Smart Investors Daily articles mentioning PRN.

PRN research

Overview

Company profile and research snapshot.

Company profile

PRN changed its tune in February 2014 but continues to provide an alternate take on US industrial firms. The old version of the fund used a multi-factor selection method coupled with a tiered equal-weighting scheme that produced a vastly different portfolio than our neutral benchmark. Currently the fund follows a Dorsey-Wright relative strength index that selects and weights stocks by price momentum. The fund selects the top, at least 30 stocks, with the highest momentum scores in the industrial space. The fund uses a full replication indexing strategy, meaning PRN will generally invest in all of the stocks of the underlying index and in proportion to the weightings. Overall, PRN offers a different, growth-focused take on industrial stocks. Investors should consider all-in costs of holding the fund. The fund is reconstituted and rebalanced quarterly. Prior to August 28, 2023, the ETF's name was Invesco DWA Industrials Momentum ETF.

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

SeekingAlpha · Oct 2, 2026

AI's Construction Boom Runs Through 2027

AI data center construction drives an industrial boom through 2027. Explore PRN & AIRR ETFs for diversified exposure—plus key risks and valuations.

Yahoo · Sep 3, 2026

Profound Medical to Participate in Lake Street’s 10th Annual Best Ideas Growth Conference

TORONTO, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative interventional MRI (iMRI) procedures, announced today that management will participate in the Lake Street Capital Markets “BIG10” Conference on September 10, 2026 in New York City. The event will consist of one-on-one investor meetings. Due to the format of the event, no webcast will be available. A

Yahoo · Sep 1, 2026

Profound Medical Further Strengthens Executive Leadership Team with Appointment of Richard Fabian as President

TORONTO, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative interventional MRI (iMRI) procedures, today announced the appointment of Richard Fabian as its new President, effective immediately. Mr. Fabian succeeds Mathieu Burtnyk, PhD, who has shifted to the newly created position of Chief Technology Officer. Mr. Fabian has an accomplished history of sales, m

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.